Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |